ZyVersa Therapeutics Inc. (ZVSA) — Financial Flexibility Index
ZyVersa Therapeutics Inc. (ZVSA) has a Financial Flexibility Index of -110.21x as of September 2025. Free cash flow of $-1.41 Billion (operating CF $-1.41 Billion minus capex $0.00) represents -110% of total liabilities ($12.77 Million). Check how tangible is ZyVersa Therapeutics Inc.'s equity to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ZyVersa Therapeutics Inc. Financial Flexibility Index (2020–2024)
Historical Financial Flexibility Index trend for ZyVersa Therapeutics Inc. across 5 annual periods. For the full cash flow conversion analysis, see cash flow conversion of ZyVersa Therapeutics Inc..
Annual Financial Flexibility Index for ZyVersa Therapeutics Inc. (2020–2024)
Year-by-year free cash flow to debt coverage for ZyVersa Therapeutics Inc.. Explore ZVSA operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.63x | $-7.56 Million | $-7.56 Million | $12.08 Million | ▲ +20.8% |
| 2023 | -0.79x | $-8.72 Million | $-8.72 Million | $11.04 Million | ▼ -199.1% |
| 2022 | -0.26x | $-4.89 Million | $-4.89 Million | $18.51 Million | ▲ +29.1% |
| 2021 | -0.37x | $-5.08 Million | $-5.08 Million | $13.63 Million | ▲ +32.6% |
| 2020 | -0.55x | $-5.11 Million | $-5.11 Million | $9.24 Million | — |